Search filters

List of works by Sally Arai

A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis

scientific article published on 09 October 2019

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation

scientific article

A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies ⬇️

scientific article published on August 9, 2011

A systematic approach to hepatic complications in hematopoietic stem cell transplantation

scientific article

Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation ⬇️

scientific article published on May 25, 2011

Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile

scientific article published on 20 April 2015

Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning

scientific article

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802

article

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease

scientific article published on 11 May 2017

Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease

scientific article

Assessment of joint and fascia manifestations in chronic graft-versus-host disease

scientific article

Association of Foxp3 regulatory gene expression with graft-versus-host disease

scientific article

Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes

scientific article published on 12 October 2017

Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease

scientific article

Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia

scientific article

Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.

scientific article

Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study

scientific article published on 2 September 2015

Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis.

scientific article published on 14 June 2017

Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant

scientific article published on 5 June 2013

Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen

scientific article

European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation

scientific article published on 30 May 2014

Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease

scientific article published on 24 February 2015

Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome

scientific article published on 16 May 2018

Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels

scientific article published on 27 April 2012

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

scientific article

Grading cardiac response in AL amyloidosis: implications for relapse and survival

scientific article published on 19 December 2018

HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity

scientific article published on 25 July 2017

Heart transplantation and cardiac amyloidosis: Approach to screening and novel management strategies ⬇️

scientific article published on November 3, 2011

Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion

scientific article published on 18 July 2002

H–Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease ⬇️

scientific article published on February 4, 2013

Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis

scientific article

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research

scientific article

Infusion of donor-derived CD8+ memory T cells for relapse following allogeneic hematopoietic cell transplantation

scientific article published on 01 March 2018

Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

scientific article published on 2 November 2015

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors

scientific article

Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvement ⬇️

scientific article published on May 28, 2013

Long-term outcomes in patients with high-risk myeloid malignancies following matched related donor hematopoietic cell transplantation with myeloablative conditioning of BU, etoposide and CY

scientific article published on 24 May 2010

Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma

scientific article published in December 2013

More than a frog in the throat: a case series and review of localized laryngeal amyloidosis.

scientific article published on May 2012

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

scientific article published in August 2002

Myxedema ascites in the posttransplant setting: case report

scientific article published on 01 November 2002

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report

scientific article

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort

scientific article published on 01 August 2019

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

scientific article published on 01 September 2020

Organ responses with daratumumab therapy in previously treated AL amyloidosis

scientific article published on 01 February 2020

Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation

scientific article published on 04 May 2020

Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents

scientific article published on 19 September 2020

Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma

scientific article published on 11 August 2020

Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study ⬇️

scientific article published on November 4, 2011

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

scientific article

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

scientific article published on 29 January 2016

Phase I/II trial of GN-BVC, a gemcitabine and vinorelbine-containing conditioning regimen for autologous hematopoietic cell transplantation in recurrent and refractory hodgkin lymphoma

scientific article

Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment

scientific article published in January 2002

Potential Association of Anti-CCR4 Antibody Mogamulizumab and Graft-vs-Host Disease in Patients With Mycosis Fungoides and Sézary Syndrome.

scientific article published in June 2018

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence ⬇️

scientific article published on May 4, 2012

Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease.

scientific article published on 04 December 2013

Rituximab in hematopoietic cell transplantation

scientific article published on June 2010

Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease

scientific article published on August 2012

Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation

scientific article

TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors

scientific article published on 07 May 2009

Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma

scientific article published on 23 May 2011

The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis ⬇️

scientific article published on February 23, 2013

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease

scientific article published on 01 March 2019

Total lymphoid irradiation-antithymocyte globulin conditioning and allogeneic transplantation for patients with myelodysplastic syndromes and myeloproliferative neoplasms

scientific article

Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients.

scientific article

Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation

scientific article

Paulina is supported by:

About Paulina

Help